Published in Trends Pharmacol Sci on September 01, 2000
Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease. Annu Rev Pharmacol Toxicol (2007) 1.74
Increased InsP3Rs in the junctional sarcoplasmic reticulum augment Ca2+ transients and arrhythmias associated with cardiac hypertrophy. Proc Natl Acad Sci U S A (2009) 1.44
Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease. Circ Arrhythm Electrophysiol (2010) 1.02
Endothelin receptor dimers evaluated by FRET, ligand binding, and calcium mobilization. Biophys J (2008) 1.01
The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth. Br J Pharmacol (2013) 1.00
Endothelin receptors: what's new and what do we need to know? Am J Physiol Regul Integr Comp Physiol (2009) 0.95
Sex differences in the modulation of K+ currents in diabetic rat cardiac myocytes. J Physiol (2003) 0.83
Modulation by endothelin-1 of spontaneous activity and membrane currents of atrioventricular node myocytes from the rabbit heart. PLoS One (2012) 0.80
Activation of calcineurin in human failing heart ventricle by endothelin-1, angiotensin II and urotensin II. Br J Pharmacol (2005) 0.77
Negative inotropic effects of endothelin-1 in mouse cardiomyocytes: evidence of a role for Na+-Ca2+ exchange. Br J Pharmacol (2007) 0.77
Alterations of caveolin-1 expression in a mouse model of delayed cerebral vasospasm following subarachnoid hemorrhage. Exp Ther Med (2016) 0.75
Thrombin-induced endothelin-1 synthesis and secretion in retinal pigment epithelial cells is rho kinase dependent. J Ocul Pharmacol Ther (2010) 0.75
Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology. Naunyn Schmiedebergs Arch Pharmacol (2001) 1.53
Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat. Br J Pharmacol (1996) 1.52
Modulation of human cardiac function through 4 beta-adrenoceptor populations. Naunyn Schmiedebergs Arch Pharmacol (1997) 1.34
(-)-CGP 12177 causes cardiostimulation and binds to cardiac putative beta 4-adrenoceptors in both wild-type and beta 3-adrenoceptor knockout mice. Mol Pharmacol (1998) 1.26
Cardiostimulant effects of urotensin-II in human heart in vitro. Br J Pharmacol (2001) 1.19
A comparative study of functional 5-HT4 receptors in human colon, rat oesophagus and rat ileum. Br J Pharmacol (1995) 1.19
Characterization and autoradiographic localization of beta-adrenoceptor subtypes in human cardiac tissues. Br J Pharmacol (1987) 1.18
Analysis of dose-response curves and calculation of agonist dissociation constants using a weighted nonlinear curve fitting program. J Pharmacol Methods (1983) 1.15
Activation of beta2-adrenergic receptors hastens relaxation and mediates phosphorylation of phospholamban, troponin I, and C-protein in ventricular myocardium from patients with terminal heart failure. Circulation (1999) 1.12
Characterization of beta-1 and beta-2 adrenoceptors in guinea pig atrium: functional and receptor binding studies. J Pharmacol Exp Ther (1987) 1.07
The affinity and efficacy of the selective beta 1-adrenoceptor stimulant RO363 at beta 1- and beta 2-adrenoceptor sites. Br J Pharmacol (1984) 1.02
Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle. J Cardiovasc Pharmacol (1993) 1.01
Is Ro 03-7894 an irreversible antagonist at beta-adrenoceptor sites? Br J Pharmacol (1984) 0.99
Molecular architecture of the human specialised atrioventricular conduction axis. J Mol Cell Cardiol (2011) 0.99
Characterization of beta 1- and beta 2-adrenoceptors in rat skeletal muscles. Biochem Pharmacol (1991) 0.99
Characterization of propranolol-resistant (-)-[125I]-cyanopindolol binding sites in rat soleus muscle. Br J Pharmacol (1993) 0.97
Autoradiographic localization of beta-1 and beta-2 adrenoceptors in guinea pig atrium and regions of the conducting system. J Pharmacol Exp Ther (1987) 0.96
Putative beta 4-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[3H]-CGP 12177 binding. Br J Pharmacol (1999) 0.95
Contractile and arrhythmic effects of endothelin receptor agonists in human heart in vitro: blockade with SB 209670. J Pharmacol Exp Ther (2000) 0.95
New views of human cardiac beta-adrenoceptors. J Mol Cell Cardiol (1989) 0.95
Validity of (-)-[3H]-CGP 12177A as a radioligand for the 'putative beta4-adrenoceptor' in rat atrium. Br J Pharmacol (1998) 0.94
The contribution of classical (beta1/2-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta3-adrenoceptor agonists of differing selectivities. J Pharmacol Exp Ther (1998) 0.91
Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists. Br J Pharmacol (1998) 0.88
Characterization and localization of atypical beta-adrenoceptors in rat ileum. Br J Pharmacol (1995) 0.86
Murine ventricular L-type Ca(2+) current is enhanced by zinterol via beta(1)-adrenoceptors, and is reduced in TG4 mice overexpressing the human beta(2)-adrenoceptor. Br J Pharmacol (2001) 0.85
Autoradiographic localization of receptors in the mammalian cardiovascular system. Clin Exp Pharmacol Physiol (1987) 0.82
Seronegative myasthenia gravis. Evidence for plasma factor(s) interfering with acetylcholine receptor function. Ann N Y Acad Sci (1993) 0.81
Cimaterol reduces beta-adrenergic receptor density in rat skeletal muscles. J Anim Sci (1992) 0.81
Chronic (-)-isoprenaline infusion down-regulates beta 1- and beta 2-adrenoceptors but does not transregulate muscarinic cholinoceptors in rat heart. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.80
Clinical and experimental observations in patients with congenital myasthenic syndromes. Ann N Y Acad Sci (1993) 0.80
Analysis of agonist dissociation constants as assessed by functional antagonism in guinea pig left atria. J Pharmacol Methods (1986) 0.80
Contribution of beta-adrenoceptor subtypes to relaxation of colon and oesophagus and pacemaker activity of ureter in wildtype and beta(3)-adrenoceptor knockout mice. Br J Pharmacol (2000) 0.79
Influence of assay buffer on dissociation constants of drugs at beta-adrenoceptor subtypes. Eur J Pharmacol (1985) 0.79
Effect of chemical sympathectomy on (-)-isoprenaline-induced changes in cardiac beta-adrenoceptor subtypes in the guinea-pig and rat. J Auton Pharmacol (1994) 0.77
Effect of the novel 5-HT4 receptor agonist DAU 6236 in human colon. Med J Aust (1994) 0.77
Effects of prolonged infusion of dopexamine on beta 1- and beta 2-adrenoceptors in guinea-pig myocardium. J Auton Pharmacol (1990) 0.77
Beta 2-adrenoreceptor binding sites in circular and longitudinal myometrial layers of the virgin guinea-pig: the influence of ovarian steroids. J Auton Pharmacol (1986) 0.77
Regulation of beta-adrenoceptors in the guinea-pig sinoatrial node. Naunyn Schmiedebergs Arch Pharmacol (1994) 0.77
Effects of chronic infusion of (-)-isoprenaline on rat cardiac muscarinic (M2)-cholinoceptors and beta 1- and beta 2-adrenoceptors. J Auton Pharmacol (1995) 0.77
The influence of molecular structure on the affinity and efficacy of some beta-adrenoceptor agonists. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.77
Changes in sensitivity of 5-HT receptor mediated functional responses in the rat oesophagus, fundus and jejunum following chronic infusion with 5-hydroxytryptamine. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.76
Beta-adrenoceptor regulation and functional responses in the guinea-pig following chronic administration of the long-acting beta 2-adrenoceptor agonist formoterol. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.76
Autoradiography of beta 1- and beta 2-adrenoceptors. Methods Mol Biol (1995) 0.76
On criteria for functional beta 3-adrenoceptors. Trends Pharmacol Sci (1997) 0.75
[Movement therapy group for psychiatric patients]. Fag Tidsskr Sykepleien (1992) 0.75
Absence of mitochondrial beta-adrenoceptors in guinea pig myocardium: evidence for tissue disparity. Gen Pharmacol (1992) 0.75
Quantitative analysis of vascular to cardiac selectivity of L- and T-type voltage-operated calcium channel antagonists in human tissues. Clin Exp Pharmacol Physiol (2000) 0.75
Beta-adrenoceptors in circular and longitudinal myometrial membranes and in lung membranes from dioestrous and post-partum guinea-pigs. Clin Exp Pharmacol Physiol (1988) 0.75
Autoradiographic localization and quantitation of beta 1- and beta 2-adrenoceptors in the human atrioventricular conducting system: a comparison of patients with idiopathic dilated cardiomyopathy and ischemic heart disease. J Mol Cell Cardiol (1994) 0.75
Signalling pathways in cardiac failure. Clin Exp Pharmacol Physiol (1995) 0.75
The affinity and efficacy of naturally occurring catecholamines at beta-adrenoceptor subtypes. J Pharm Pharmacol (1985) 0.75
Beta-adrenoceptor subtypes in the atrioventricular conducting system and myocardium of spontaneously hypertensive rats: effects of angiotensin-converting enzyme inhibition by perindopril. J Cardiovasc Pharmacol (1994) 0.75
Comparison of beta-adrenoceptor populations in cat and guinea-pig left atria. J Pharm Pharmacol (1985) 0.75